High coverage and safety of influenza A (H1N1) 2009 monovalent vaccination among health care personnel in Thailand

American Journal of Infection Control

Volumn 39, Issue 6, 2011, Pages 525-528

  Kiertiburanakul, Sasisopin ^a   Malathum, Kumthorn ^a   Watcharananan, Siriorn P ^a   Bunupuradah, Pakwan ^a   Piebpien, Pongsathorn ^a   Rujiraviroj, Usa ^a   Likitsinsipon, Wanida ^a   Apivanich, Siriluk ^a   Kehachindawat, Pranee ^a   Burakitcharoen, Rungtipa ^a   Leelaudomlipi, Surasak ^a   Wananukul, Winai ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Adverse effect; H1N1; health care personnel; influenza A; Panenza; vaccine

Indexed keywords

INFLUENZA VACCINE;

ADULT; AGED; ARTICLE; CHILL; CONJUNCTIVITIS; COUGHING; DROWSINESS; DRUG ERUPTION; DRUG FEVER; DRUG INDUCED HEADACHE; FATIGUE; FEMALE; FLUSHING; HEALTH CARE PERSONNEL; HEART PALPITATION; HUMAN; INFLUENZA A (H1N1); INFLUENZA VACCINATION; INJECTION SITE REACTION; MALE; MUSCLE CRAMP; MYALGIA; NAUSEA; PRURITUS; RHINORRHEA; SIDE EFFECT; SORE THROAT; SYNCOPE; THAILAND; VOMITING;

ADULT; FATIGUE; FEMALE; HEALTH PERSONNEL; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; THAILAND; VACCINATION;

EID: 79960955505     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2010.09.011     Document Type: Article

References (10)

1. Center for Disease Control and Prevention (CDC). Swine influenza A (H1N1) infection in two children - southern California, March-April 2009. MMWR Morb Mortal Wkly Rep 2009;58:400-2.
2. Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 2009;459:931-9.
3. Kiertiburanakul S, Apivanich S, Muntajit T, Sukkra S, Sirinavin S, Leelaudomlipi S, et al. H1N1 2009 influenza among healthcare workers in a tertiary care hospital in Thailand. J Hosp Infect 2010;74:300-2.
4. World Health Organization (WHO). WHO recommendations on pandemic (H1N1) 2009 vaccines. Pandemic (H1N1) 2009 briefing note 2. Available from: http://www.who.int/csr/disease/swineflu/notes/h1n1-vaccine-20090713/en/index. html. Accessed January 8, 2011.
5. Centers for Disease Control and Prevention (CDC). Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Morb Mortal Wkly Rep 2009;58:1-8.
6. Centers for Disease Control and Prevention (CDC). Interim results: influenza A (H1N1) 2009 monovalent and seasonal influenza vaccination coverage among health-care personnel, United States, August 2009-January 2010. MMWR Morb Mortal Wkly Rep 2010;59:357-62.
7. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45. (Pubitemid 12149145)
8. Centers for Disease Control and Prevention (CDC). Safety of influenza A (H1N1) 2009 monovalent vaccines, United States, October 1-November 24, 2009. MMWR Morb Mortal Wkly Rep 2009;58:1351-6.
9. Vajo Z, Tamas F, Sinka L, Jankovics I. Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-2010 influenza season: a multicentre, randomised controlled trial. Lancet 2010;375:49-55.
10. Liang X, Wang H, Wang J, Fang H, Wu J, Zhu F, et al. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 2010;375:56-66.